FOSUN HEALTH Logo

Brain Metastases Causes

catalogue

Brain Metastases Causes

Brain Metastases Causes

A brain metastasis happens when cancer cells leave the original tumour, travel through the bloodstream, and settle in the brain. What determines whether that happens is the biology of the cancer — its type, how far it has already spread, and the molecular markers it carries — rather than anything about the patient's diet, stress or habits. For the commonest sources, the risk is high enough that guidelines recommend imaging the brain at defined intervals during treatment.

How cancer reaches the brain

The process is understood in outline, and it explains why the brain is a destination for certain cancers rather than a random one:

  • Cells leave the original tumour and enter the bloodstream, which requires them to survive the journey and to avoid being removed by the immune system.
  • They arrive in the brain through the circulation, which receives a large share of the blood flow leaving the heart, and settle where the vessels are narrow enough to trap them.
  • They must then grow in the brain, which is a different environment from the organ they came from, and most cells that arrive do not succeed in establishing themselves.
  • The deposits are usually multiple, since the cells are distributed by the bloodstream rather than growing outwards from one point — which is why the whole brain is imaged rather than only the area that caused symptoms.

This description also makes clear what treatment is aimed at. Because the cells arrive through the bloodstream, further cells may arrive later; and because the brain is a single compartment, the deposits within it are counted and treated as a whole. That is why the number of deposits, rather than the size of any one of them, is the core of the decision, and why repeat imaging at intervals is part of treatment rather than an afterthought.

Which cancers spread to the brain most often

Any cancer can reach the brain, but a small number account for most cases, and the pattern is stable enough to be useful:

  • Lung cancer is the commonest source by a wide margin. Part of the reason is simply how common it is; part is that the disease is often found at a stage where spread has already occurred. Deposits are frequently found on staging scans before they cause symptoms.
  • Breast cancer reaches the brain particularly in the HER2-positive and triple-negative subtypes, and often later in the course of the disease — more often now, in part because control of the cancer elsewhere has improved.
  • Melanoma has a well-recognised tendency to spread to the brain. It can produce several deposits at once, and bleeding into a deposit is more common here than with other cancers.
  • Kidney cancer can present with a single deposit that bleeds, and is one of the types in which removal is considered more readily.
  • Other cancers and unknown primary — cancers of the ovary, uterus, head and neck and others may spread to the brain, and in a minority of patients the deposit is found before the original cancer has been identified, which makes the search for the source part of the diagnosis.

How the stage and the markers change the risk

Beyond the type of cancer, two further features determine how likely spread to the brain is, and both are matters of record rather than of chance:

  • How far the cancer has already spread — a cancer that has reached the lymph nodes or another organ is more likely to reach the brain, because the process that allows it to spread has already happened. This is why a deposit is often found in the setting of disease that is already being treated elsewhere.
  • The molecular subtype — in lung cancer, EGFR-mutant and ALK-rearranged disease has a higher rate of spread to the brain than other subtypes. In breast cancer, the HER2-positive and triple-negative subtypes behave similarly. In melanoma, a BRAF mutation is associated with a higher risk.
  • Why this matters rather than merely being of interest — the same markers that raise the risk also open the possibility of drug treatment that reaches the brain, so the finding is simultaneously a risk factor and a treatment option.

What is not on this list is important too. The likelihood of spread to the brain is not increased by diet, by stress, by physical activity, or by any decision the patient made. Patients frequently ask what they did wrong, and in this disease the answer is that the risk comes from the biology of the cancer, and the useful response is to make sure the markers have been tested and that the surveillance the guidelines recommend is actually being carried out.

Explanations that are not supported

Several widely repeated explanations for cancer spreading to the brain can be set aside, and doing so is useful because it redirects attention to what can be acted on:

  • Diet and supplements. No diet, vitamin, herb or supplement has been shown to cause cancer to spread to the brain, and none has been shown to prevent it. Some supplements interact with cancer drugs, which makes taking them without discussion a real risk.
  • Stress and emotional state. Psychological stress does not cause a cancer to spread. Assuming that it does places a burden of blame on patients that the evidence does not support.
  • Mobile phones, head injury, dental work and air travel. None has been shown to cause deposits in the brain in patients with cancer. These explanations circulate because they are memorable, not because they are supported.
  • Biopsy or surgery causing spread. This is a common worry that is not supported: procedures used for diagnosis or removal do not cause a cancer to reach the brain. Declining a needed biopsy on this basis leaves the diagnosis and the treatment weaker.

The counterweight to these myths is that the risk factors which do matter can be assessed and acted on. Making sure the molecular profile of the cancer has been tested, that the imaging surveillance recommended for that cancer type is being carried out, and that new neurological symptoms are assessed promptly are all steps that follow from the evidence, and none of them depends on anything the patient is doing wrong.

Family history and inherited risk

Questions about family risk are common, and the answer here is different from the answer for cancers with a strong inherited component:

  • The spread of a cancer to the brain is not inherited. What is inherited, in a minority of families, is a tendency to develop certain cancers at all — and some of those cancers are among the types that reach the brain.
  • Recognised inherited conditions matter for the primary cancer, not for the metastasis itself. Where several close relatives have had a cancer at an unusually young age, or where the same cancer has occurred across generations, a referral for genetic assessment is reasonable.

Who is at higher risk, and who is not

Bringing the factors together makes the picture usable at the level of an individual patient:

  • Risk is higher with lung cancer, breast cancer, melanoma, colorectal cancer or kidney cancer; with disease that has already spread beyond its original site; and with certain molecular subtypes, including EGFR-mutant and ALK-rearranged lung cancer, HER2-positive and triple-negative breast cancer, and BRAF-mutant melanoma.
  • Risk is lower with cancers that only rarely reach the brain, and with disease that remains confined to its original organ after treatment.
  • Risk is not affected by diet, supplements, stress, physical activity, mobile phone use, previous head injury, or by how a cancer was treated.
  • What follows from being at higher risk — imaging of the brain at the intervals recommended for that cancer, attention to the symptoms described on the symptoms page, and confirmation that the tumour's molecular markers have been tested, since those markers affect both the risk and the treatment options.

Frequently Asked Questions

Did anything I did cause the cancer to spread to my brain?

No. The spread of a cancer to the brain is determined by the biology of the cancer itself — its type, how far it had already spread, and the molecular markers it carries — and not by diet, stress, physical activity, or any decision the patient made. This is worth stating plainly, because the opposite belief is common and places a burden that the evidence does not support. The factors that can be acted on are different ones: making sure the tumour has been tested for the markers that affect both risk and treatment, keeping to the imaging surveillance recommended for that cancer type, and having new neurological symptoms assessed promptly.

Should I have my brain scanned regularly if I have cancer?

It depends on the cancer. For several types with a recognised tendency to reach the brain — certain lung cancers, HER2-positive or triple-negative breast cancer, and melanoma that has spread — imaging of the brain at defined intervals is recommended during treatment, and it is reasonable to ask whether the surveillance that applies to your cancer is being carried out. For other cancers the likelihood is low enough that routine imaging of the brain is not recommended, because scans without a reason frequently find things that are not cancer and lead to further investigation. Either way, a new neurological symptom is a reason to image, whatever the schedule says.

Can a deposit in the brain appear years after treatment?

Yes, and this is why follow-up continues. Spread to the brain can occur years after the original cancer was treated, particularly with breast cancer and melanoma, and it can also occur while the cancer elsewhere appears to be under control. That pattern is one of the reasons imaging of the brain is included in the follow-up of certain cancers, and why a symptom appearing long after treatment should still be assessed rather than attributed to something else. The interval at which the risk is highest differs by cancer type, which is why the schedule is set for the cancer rather than for the patient's general condition.

If my relative had cancer that spread to the brain, am I at risk?

The spread itself is not inherited, so a relative having a deposit in the brain does not raise your own risk of the same event. What can run in families is a tendency to develop certain cancers — and since some of those cancers are among the types that reach the brain, a family history of several cancers at unusually young ages, or of the same cancer across generations, is worth raising with a doctor, because genetic assessment and a surveillance programme may be appropriate for the primary cancer. Relatives do not need brain imaging simply because a family member developed a deposit.

Ask what surveillance applies to your cancer

Send the pathology report with the molecular results, the record of the cancer's diagnosis and treatment with dates, the most recent imaging of the chest and abdomen, and a description of any new symptoms with the date they began. Our team will return a written assessment within 48 hours of the file being complete, including whether imaging of the brain is indicated and how often.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*